Camlin Fine Sciences Ltd

Camlin Fine Sciences Ltd., a small-cap specialty chemicals manufacturer, reported a consolidated net profit of ₹88.20 crores for Q4 FY26, marking an alarming reversal from a loss of ₹0.72 crores in Q4 FY25. However, this headline figure masks severe operational deterioration, as the company's standalone business slipped into losses whilst grappling with margin compression and a soaring interest burden. The stock, currently trading at ₹129.10, has plunged 46.80% over the past year, significantly underperforming both the Sensex and its specialty chemicals peer group.

The Sensex edged down 0.05% on 27 May 2026, while Camlin Fine Sciences Ltd surged 7.5%, marking a notable 4.56 percentage-point outperformance over its Specialty Chemicals sector. This sharp intraday gain rewrites the short-term narrative for the stock, raising questions about whether this is a genuine recovery or a relief rally within a broader downtrend.

Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

The Sensex advanced 0.55% on 15 May 2026, yet Camlin Fine Sciences Ltd outpaced the broader market with a robust 7.09% gain, touching an intraday high of Rs 132.05. This 6.36-percentage-point outperformance over the Specialty Chemicals sector signals a distinctly stock-specific rally rather than a market-wide lift.

Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Feb 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 May 2026, providing investors with the latest insights into the company’s performance and outlook.

The Sensex advanced 0.93% on 14 May 2026, yet Camlin Fine Sciences Ltd outpaced the broader market with a robust 7.57% gain, reaching an intraday peak of Rs 128.55. This 4.47-percentage-point outperformance over the Specialty Chemicals sector’s 3.1% rise signals a distinctly stock-specific rally rather than a mere market tailwind.

Camlin Fine Sciences Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade, despite a recent uptick in its share price. This change reflects a complex interplay of sky-high price-to-earnings ratios and modest returns on capital, positioning the stock as a cautious prospect within the specialty chemicals sector.

Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Camlin Fine Sciences Ltd, a specialty chemicals company, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. Despite a modest day change of -0.09%, the stock’s price-to-earnings (P/E) ratio has surged to an extraordinary 1,431.53, signalling a significant reappraisal of its price attractiveness relative to historical and peer benchmarks.

Camlin Fine Sciences Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in price momentum, reflected in a complex array of technical indicators. Despite a recent 5.79% surge in daily price, the company’s overall technical outlook remains cautious, with several bearish signals persisting alongside emerging bullish trends.

Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 April 2026, providing investors with the latest perspective on the company’s position.

The Sensex declined 0.62% on 23 Apr 2026 while Camlin Fine Sciences Ltd surged 10.08%, outperforming its Specialty Chemicals sector by 7.13 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.

Camlin Fine Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 April 2026, providing investors with the latest insights into the company’s performance and outlook.

The Sensex advanced 3.59% on 8 Apr 2026, yet Camlin Fine Sciences Ltd outpaced the broader market with a 7.31% gain, reaching an intraday high of Rs 111.81. This 3.85-percentage-point outperformance over the Specialty Chemicals sector’s 2.84% rise highlights a distinctly stock-specific rally rather than a market-wide lift.

The Sensex gained 2.76% on 1 Apr 2026, yet Camlin Fine Sciences Ltd outpaced both the benchmark and its sector peers with a robust 10.86% intraday surge, reaching a high of Rs 107.5. This 6.47-percentage-point outperformance over the Specialty Chemicals sector’s 4.39% gain signals a distinctly stock-specific rally rather than a mere market tailwind.